HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Pharmacovigilance
  • >PSUR
  • >Informal PSUR Worksharing
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • COVID-19
    • BREXIT
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
      • General Information
      • Referrals
      • PSUR
        • PSUR Single Assessment
        • Informal PSUR Worksharing
        • Outcome of informal PSUR worksharing procedures
        • PSUSA Follow-up
        • Outcome of PSUR Follow-up procedures
        • PSUR Work Sharing and Synchronisation Project
      • RMP
      • Article 57
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

Informal PSUR Worksharing

  • Best Practice Guide on (1) Introduction of substances/combinations onto the EURD list and setting the initial PSUR DLP and frequency and (2) Assessment of PSURs of products where the EU Reference Date is not yet legally binding (March 2017)
  • Template - PSUR Assessment Report

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/pharmacovigilance/psur/bpg-on-1-introduction-of-substances/combinations-onto-the-eurd-list-and-setting-the-initial-psur-dlp-and-frequency-and-2-assessment-of-psurs-of-products-where-the-eu-reference-date-is-not-yet-legally-binding.html